Promoting remyelination in multiple sclerosis.

J Neurol · 2021 · PMC7815564 · PMID 31190170

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

A subset of participants from the SYNERGY trial (discussed above) showed a trend toward neurofilament light decline among treatment responders [ 161 ]; however such measures remain an indirect marker of remyelination and, in our view, should remain exploratory.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.